Microfluidic model for in vitro acute Toxoplasma gondii infection and transendothelial migration

被引:5
|
作者
Kim, Hyunho [1 ,2 ]
Hong, Sung-Hee [3 ]
Jeong, Hyo Eun [1 ]
Han, Sewoon [4 ]
Ahn, Jinchul [1 ]
Kim, Jin-A. [1 ]
Yang, Ji-Hun [5 ]
Oh, Hyun Jeong [1 ]
Chung, Seok [1 ,6 ]
Lee, Sang-Eun [3 ]
机构
[1] Korea Univ, Sch Mech Engn, Seoul, South Korea
[2] Massachusetts Gen Hosp, Res Inst, Ctr Syst Biol, Boston, MA 02114 USA
[3] Korea Dis Control & Prevent Agcy, Div Vectors & Parasit Dis, Cheongju, South Korea
[4] CellFE, Alameda, CA USA
[5] Next & Bio, Seoul, South Korea
[6] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
MURINE MACROPHAGES; ENDOTHELIAL-CELLS; TACHYZOITES; INHIBITION; MODULATION; CULTURE; MYOSIN; EGRESS; GROWTH; GAMMA;
D O I
10.1038/s41598-022-15305-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The protozoan parasite Toxoplasma gondii (T. gondii) causes one of the most common human zoonotic diseases and infects approximately one-third of the global population. T. gondii infects nearly every cell type and causes severe symptoms in susceptible populations. In previous laboratory animal studies, T. gondii movement and transmission were not analyzed in real time. In a three-dimensional (3D) microfluidic assay, we successfully supported the complex lytic cycle of T. gondii in situ by generating a stable microvasculature. The physiology of the T. gondii-infected microvasculature was monitored in order to investigate the growth, paracellular and transcellular migration, and transmission of T. gondii, as well as the efficacy of T. gondii drugs.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Efficacy of clofazimine against acute and chronic Toxoplasma gondii infection in mice
    Biglari-Moghadam, Nooshin
    Najafzadehvarzi, Hossein
    Gorgani-Firouzjaee, Tahmineh
    Ghasemi-Kasman, Maryam
    MICROBIAL PATHOGENESIS, 2023, 181
  • [42] The opposing effect of acute and chronic Toxoplasma gondii infection on tumor development
    Song, Yining
    Yuan, Hao
    Yang, Xiaoying
    Yang, Zipeng
    Ren, Zhaowen
    Qi, Shuting
    He, Houjing
    Zhang, Xiu-Xiang
    Jiang, Tiantian
    Yuan, Zi-Guo
    PARASITES & VECTORS, 2024, 17 (01):
  • [43] Effects of dextran sulfates on the acute infection and growth stages of Toxoplasma gondii
    Ishiwa, Akiko
    Kobayashi, Kyousuke
    Takemae, Hitoshi
    Sugi, Tatsuki
    Gong, Haiyan
    Recuenco, Frances C.
    Murakoshi, Fumi
    Inomata, Atsuko
    Horimoto, Taisuke
    Kato, Kentaro
    PARASITOLOGY RESEARCH, 2013, 112 (12) : 4169 - 4176
  • [44] Tracking acute phase protein response during acute and chronic Toxoplasma gondii infection
    Atmaca, Hasan Tarik
    Gazyagci, Aycan Nuriye
    Terzi, Osman Safa
    Dincel, Gungor Cagdas
    Sumer, Tugce
    LABORATORY ANIMAL RESEARCH, 2019, 35 (01)
  • [45] Tracking acute phase protein response during acute and chronic Toxoplasma gondii infection
    Hasan Tarik Atmaca
    Aycan Nuriye Gazyagci
    Osman Safa Terzi
    Gungor Cagdas Dincel
    Tugce Sumer
    Laboratory Animal Research, 35
  • [46] KINETICS OF IN VITRO IMMUNOINACTIVATION OF TOXOPLASMA GONDII
    STRANNEGARD, O
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA, 1967, 71 (03): : 450 - +
  • [47] Toxoplasma gondii in vitro culture for experimentation
    Chatterton, JMW
    Evans, R
    Ashburn, D
    Joss, AWL
    Ho-Yen, DO
    JOURNAL OF MICROBIOLOGICAL METHODS, 2002, 51 (03) : 331 - 335
  • [48] A Role for Basigin in Toxoplasma gondii Infection
    Nasuhidehnavi, Azadeh
    Zhao, Yanlin
    Punetha, Ankita
    Hemphill, Andrew
    Li, Hong
    Bechtel, Tyler J.
    Rager, Theresa
    Xiong, Bingcong
    Petrou, Vasileios, I
    Gubbels, Marc-Jan
    Weerapana, Eranthie
    Yap, George S.
    INFECTION AND IMMUNITY, 2022, 90 (08)
  • [49] TOXOPLASMA-GONDII - INFECTION AND PROPHYLAXIS
    HOF, H
    MEDIZINISCHE KLINIK, 1978, 73 (24) : 888 - 899
  • [50] Behavioral biology of Toxoplasma gondii infection
    Wen Han Tong
    Chris Pavey
    Ryan O’Handley
    Ajai Vyas
    Parasites & Vectors, 14